Chemical activators of OR12D2 can be characterized by their ability to influence the signaling pathways which lead to its activation. Forskolin, a well-known adenylyl cyclase activator, directly increases the levels of cAMP within the cell. This surge in cAMP activates protein kinase A (PKA), a kinase that can phosphorylate various target proteins, potentially including OR12D2, thereby altering its conformation and enhancing its activity. Similarly, isoproterenol, a beta-adrenergic agonist, also elevates cAMP levels through stimulation of beta-adrenergic receptors, which indirectly promotes PKA activity and the consequent activation of OR12D2. The non-specific phosphodiesterase inhibitor IBMX prevents cAMP degradation, ensuring that PKA remains active and capable of activating OR12D2 through phosphorylation. Analogous in their effects, cilostamide and anagrelide, both PDE3 inhibitors, and rolipram, a PDE4 inhibitor, elevate intracellular cAMP, perpetuating PKA activation and thus providing a biochemical environment conducive to OR12D2 activation.
On another front, sildenafil and tadalafil, inhibitors of PDE5, prevent the breakdown of cGMP, thus maintaining the activation of protein kinase G (PKG). PKG can then act on proteins like OR12D2, activating them through phosphorylation. Capsaicin engages with the TRPV1 receptor and can initiate a cascade of downstream signaling that may include the activation of kinases capable of OR12D2 activation. The role of essential trace elements like zinc and copper, often acting as enzyme cofactors, is also significant. Zinc can influence various enzymes that modulate signaling pathways, potentially leading to OR12D2 activation. Similarly, copper can participate in enzymatic reactions that might culminate in OR12D2 activation. Lastly, genistein, a tyrosine kinase inhibitor, can alter cellular phosphorylation patterns, which may have implications for the activation state of OR12D2, suggesting that the presence of genistein can create a condition favorable for the activation of OR12D2 by impacting the phosphorylation status of proteins within the cell.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Activates adenylyl cyclase, increasing cAMP levels, which in turn activates protein kinase A (PKA). PKA phosphorylates target proteins, which can lead to the functional activation of OR12D2 by changing its conformation or its interaction with other molecules. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
Beta-adrenergic agonist that binds to beta-adrenergic receptors, causing an increase in cAMP and activation of PKA, which could phosphorylate and activate OR12D2. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
Non-specific phosphodiesterase inhibitor that prevents cAMP degradation, maintaining PKA activation. PKA may then phosphorylate and activate OR12D2. | ||||||
Cilostamide (OPC 3689) | 68550-75-4 | sc-201180 sc-201180A | 5 mg 25 mg | $90.00 $350.00 | 16 | |
PDE3 inhibitor that increases cAMP levels, leading to PKA activation and potential phosphorylation and activation of OR12D2. | ||||||
Capsaicin | 404-86-4 | sc-3577 sc-3577C sc-3577D sc-3577A | 50 mg 250 mg 500 mg 1 g | $94.00 $173.00 $255.00 $423.00 | 26 | |
Binds and activates the TRPV1 receptor, which could lead to the activation of downstream signaling molecules or kinases that phosphorylate and activate OR12D2. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $47.00 | ||
As an essential trace element, zinc can act as a cofactor for various enzymes and proteins, potentially influencing signaling pathways that lead to the activation of OR12D2. | ||||||
Copper(II) sulfate | 7758-98-7 | sc-211133 sc-211133A sc-211133B | 100 g 500 g 1 kg | $45.00 $120.00 $185.00 | 3 | |
Copper can serve as a cofactor in various enzymatic reactions that could lead to the activation of signaling pathways involving OR12D2. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
PDE4 inhibitor that increases cAMP levels, leading to PKA activation, which could phosphorylate and activate OR12D2. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Tyrosine kinase inhibitor which might lead to altered phosphorylation patterns in the cell, potentially affecting the activation state of OR12D2. | ||||||
Anagrelide | 68475-42-3 | sc-491875 | 25 mg | $147.00 | ||
PDE3 inhibitor increasing cAMP levels, which leads to activation of PKA. PKA may subsequently phosphorylate and activate OR12D2. | ||||||